Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
12.87
+0.04 (0.31%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Daxor Market Cap
Daxor has a market cap or net worth of $64.15 million as of October 16, 2025. Its market cap has increased by 39.52% in one year.
Market Cap
64.15M
Enterprise Value
63.57M
1-Year Change
39.52%
Ranking
Category
Stock Price
$12.87
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $64.15M, an increase of 111.95%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 63.95M | 71.82% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.98B |
| Johnson & Johnson | 458.02B |
| AbbVie | 403.57B |
| UnitedHealth Group | 325.85B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 230.47B |